Losartan 25 mg
INDICATIONS AND USAGE Hypertension Losartan potassium tablets USP are indicated for the treatment of hypertension. It may be used alone or in combination with other antihypertensive agents, including diuretics. Hypertensive Patients with Left Ventricular Hypertrophy Losartan potassium tablets USP are indicated to reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy, but there is evidence that this benefit does not apply to Black patients. (See PRECAUTIONS, Race and CLINICAL PHARMACOLOGY, Pharmacodynamics and Clinical Effects, Reduction in the Risk of Stroke, Race ). Nephropathy in Type 2 Diabetic Patients Losartan potassium tablets USP are indicated for the Treatment of diabetic nephropathy with an elevated serum creatinine and proteinuria (urinary albumin to creatinine ratio ≥300 mg/g) in patients with type 2 diabetes and a history of hypertension. In this population, losartan potassium tablets USP reduces the rate of progression of nephropathy as measured by the occurrence of doubling of serum creatinine or end stage renal disease (need for dialysis or renal transplantation) (see CLINICAL PHARMACOLOGY, Pharmacodynamics and Clinical Effects ).
Legacy Pharmaceutical Packaging, LLC
OVAL WHITE LU P21
LU P21 OVAL WHITE
Related Pills
Losartan Potassium 100 MG Oral Tablet
Legacy Pharmaceutical Packaging, LLC
Losartan Potassium 25 MG Oral Tablet
Legacy Pharmaceutical Packaging, LLC
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
HOW SUPPLIED Losartan Potassium Tablets USP, 25 mg are white, capsule shaped, biconvex, film-coated tablets, debossed with 'LU' on one side and 'P21' on the other side. They are supplied as follows: NDC 68645-524-70 – Unit of Dose of 30 Losartan Potassium Tablets USP, 50 mg are white, capsule shaped, biconvex, film-coated tablets, debossed with 'L' and 'U' on either side of breakline on one side and 'P22' on the other side. They are supplied as follows: NDC 68645-525-70 – Unit of Dose of 30 Losartan Potassium Tablets USP, 100 mg are white, capsule shaped, biconvex, film-coated tablets, debossed with 'LU' on one side and 'P23' on the other side. They are supplied as follows: NDC 68645-526-70 – Unit of Dose of 30 Storage Store at 25°C (77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. Keep container tightly closed. Protect from light.
More pills like OVAL LU P21